Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Ductal Carcinoma In Situ|Breast Lobular Carcinoma In Situ|Stage 0 Breast Cancer AJCC v6 and v7|Stage I Breast Cancer AJCC v7|Stage IA Breast Cancer AJCC v7|Stage IB Breast Cancer AJCC v7|Stage II Breast Cancer AJCC v6 and v7|Stage IIA Breast Cancer AJCC v6 and v7|Stage IIB Breast Cancer AJCC v6 and v7|Stage III Breast Cancer AJCC v7|Stage IIIA Breast Cancer AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIC Breast Cancer AJCC v7
Interventions: DRUG: Endoxifen Hydrochloride|OTHER: Placebo Administration|OTHER: Questionnaire Administration
Sponsor: National Cancer Institute (NCI)